General Information of This Payload
Payload ID
PAY0ZXOON
Name
Nostocyclopeptide-1
Synonyms
Nostocyclopeptide-1
   Click to Show/Hide
Structure
Formula
C46H66ClN5O7S
Isosmiles
C[C@H]([C@@H]1[C@H](O1)C2=CC=C(CN3CCN(CC3)CCC(C)(S)C)C=C2)[C@@H](OC([C@@H](NC(C(C)(C)CN4)=O)CC(C)C)=O)C/C=C/C(N[C@@H](C4=O)CC5=CC=C(OC)C(Cl)=C5)=O
InChI
InChI=1S/C46H66ClN5O7S/c1-29(2)24-36-43(55)58-37(30(3)40-41(59-40)33-15-12-31(13-16-33)27-52-22-20-51(21-23-52)19-18-46(6,7)60)10-9-11-39(53)49-35(26-32-14-17-38(57-8)34(47)25-32)42(54)48-28-45(4,5)44(56)50-36/h9,11-17,25,29-30,35-37,40-41,60H,10,18-24,26-28H2,1-8H3,(H,48,54)(H,49,53)(H,50,56)/t30-,35+,36-,37-,40+,41+/m0/s1
InChIKey
XYHIRUMIFCUCBH-ZSLYCBLHSA-N
Pharmaceutical Properties
Molecule Weight
868.582
Polar area
141.84
Complexity
1756.481175
xlogp Value
5.9132
Heavy Count
60
Rot Bonds
13
Hbond acc
10
Hbond Donor
4
Each Antibody-drug Conjugate Related to This Payload
Full Information of The Activity Data of The ADC(s) Related to This Payload
MORAb-003 ADC1 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
0.41 nM
High FRA expression (FRA +++)
Method Description
Use crystal violet analysis to evaluate the in vitro efficacy of the prepared ADCs. Initially screen all MORAb003 ADCs on IGROV1 (FRi (+++)) and SJSA - 1 (FReg (-)) cells.
In Vitro Model Osteosarcoma SJSA-1 cells CVCL_1697
References
Ref 1 Fan bracket